Christopher Fraser,Takashi Kei Kishimoto,Roberto A. Maldonado
申请号:
US14810450
公开号:
US20160022650A1
申请日:
2015.07.27
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class I-restricted and/or MHC Class II-restricted epitopes associated with undesired CD8+ T cell responses and immunosuppressants that provide tolerogenic immune responses against antigens that comprise the epitopes.